Irbesartan Tablet
Product Images NDC 46708-441

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 46708-441). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets In 1 Hdpe Bottle (Irbesartan 150mg)

Label for Irbesartan Tablets USP 150 mg oral tablets by Alembic Pharmaceuticals Limited. The label indicates a package containing 30 tablets with storage instructions and manufacturer details. The NDC number 46708-440-30 and a barcode are visible, alongside dosage and shelf life placeholders.*

FDA Label Image

30 Tablets In 1 Hdpe Bottle (Irbesartan 300mg)

Label for Irbesartan Tablets, USP 300 mg strength, manufactured by Alembic Pharmaceuticals Limited. The label indicates a 30-tablet package size, includes the NDC number 46708-441-30, storage instructions at 25°C with permitted excursions, and a barcode. It states the product is prescription only.*

FDA Label Image

30 Tablets In 1 Hdpe Bottle (Irbesartan 75mg)

Label for Irbesartan Tablets, USP 75 mg oral tablets by Alembic Pharmaceuticals Limited. The label states 30 tablets per package, prescription use only, and includes storage instructions and manufacturer information. The label also displays an NDC barcode and manufacturing license number.*

FDA Label Image

Figure 1 And 2 (Irbesartan Fig1 2)

Two graphs showing the placebo-subtracted reduction in blood pressure with IRBESARTAN dose. The left graph (Figure 1) depicts the reduction in trough systolic blood pressure (SeSBP) in mmHg versus irbesartan dose in mg/day, and the right graph (Figure 2) shows the reduction in trough diastolic blood pressure (SeDBP) in mmHg versus irbesartan dose in mg/day. Both graphs illustrate an integrated analysis with data points and fitted curves.*

FDA Label Image

Figure 3 (Irbesartan Fig3)

A line graph comparing cumulative event rates over 60 months of follow-up among three groups: Irbesartan, Amlodipine, and Placebo. The y-axis shows cumulative event rate in percentage, and the x-axis shows months of follow-up. The graph includes a small inset table showing relative risk (RR) and p-values for Irbesartan vs Placebo and Irbesartan vs Amlodipine comparisons.*

FDA Label Image

Structure (Irbesartan Str)

Chemical structure diagram of Irbesartan, the active ingredient for this oral tablet medication by Alembic Pharmaceuticals Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.